Search results
Moderna (NASDAQ:MRNA) Stock Price Down 3.9% After Insider Selling
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report)’s share price fell 3.9% during trading on Tuesday following insider selling activity. 1,055,980 shares changed hands during mid-day ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 3 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Gateway - Quartz
Quartz· 6 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial. The pharma < ...
FDA advises vaccine manufacturers to make COVID-19 booster targeting KP.2 strain
ABC Action News Tampa Bay· 9 hours agoThe FDA has issued an updated recommendation for the fall COVID-19 vaccine formula. "Coverage in the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoBiotech stocks hit a two-year high in February, but have trended sideways in the months since...
Army linked soldier's heart condition to COVID vaccine, former CBS News journalist reports
WCHS-TV· 9 hours agoThe U.S. Army and National Guard acknowledged a soldier’s “debilitating heart condition” is...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 6 days agoRasmussen Reports used to be a fairly creditable and credible political polling organization, good...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 3 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...